Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ATS 9. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Mg/Zn catalyzed route for Atorvastatin calcium intermediate. Reduces EHS risk and cost. Reliable supplier for pharma intermediates.
Patent CN109503542B reveals a green synthesis for Atorvastatin intermediates, eliminating toxic cyanides and reducing EHS risks for reliable API manufacturing.